Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indian markets nosedive
Wed, 3 Jun 01:30 pm

After opening the day in red, the Indian share markets marched further south in the afternoon. Except software, all sectoral indices are trading in red. FMCG and consumer durables sectors are bearing the maximum brunt.

The BSE-Sensex is down 277 points (1.02%) and the NSE-Nifty is trading 80 points down (0.96%). The S&P BSE Midcap index is trading lower by 1.7% and the S&P BSE Smallcap index is trading down by 2.5%. Gold prices, per 10 grams, are trading at Rs 26,890 levels. Silver price, per kilogram, is trading at Rs 38,370 levels. Crude oil is trading at Rs 3,892 per barrel. The rupee is trading at 63.93 to the US dollar.

Majority of stocks in the pharma sector are trading in red today with Orchid Chemicals and Dishman Pharma leading the losses. As per a leading financial daily, Sun Pharma has entered into an agreement with AstraZeneca Pharma. The agreement is for distributing the latter's Axcer brand which is used for the treatment of acute coronary syndrome. This will strengthen Sun Pharmaceutical's cardiology portfolio with the addition of a new patented therapy. The company stated that such collaborations are a part of company's policy of becoming the partner of choice for promotion and distribution of innovative pharmaceutical products. Stock of Sun Pharma is currently trading down by 1.6%.

Food and Tobacco stocks are also trading on a negative note. Stock of Nestle is witnessing selling pressure and plunged by over 9% as the Delhi government confirmed the results of lab test of Maggi noodles and stated that the samples of Maggi noodles failed to meet food safety norms and are unsafe. The samples tested were found to be carrying lead more than the permissible limit. The Delhi government is likely to impose a heavy fine against Nestle for selling unsafe products. Currently shares of nestle are trading down nearly 9.5%.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian markets nosedive". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.